Dendritic cell vaccination against ovarian cancer - tipping the Treg/T(H)17 balance to therapeutic advantage? Mar 2011 - Expert Opin Biol Ther; 11(4):1744-7682 [PMID:21271951] [Cannon MJ] [Goyne H] [Stone PJ] [Chiriva-Internati M]
Cellular immunotherapy for ovarian cancer. May 2009 - Expert Opin Biol Ther; 9(6):1744-7682 [PMID:19456205] [Cannon MJ] [O'Brien TJ]
Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial. Mar 2008 - J. Virol.; 82(4):1098-5514 [PMID:18057249] [Santin AD] [Bellone S] [Palmieri M] [Zanolini A] [Ravaggi A] [Siegel ER] [Roman JJ] [Pecorelli S] [Cannon MJ]
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. Mar 2006 - Gynecol. Oncol.; 100(3):0090-8258 [PMID:16249018] [Santin AD] [Bellone S] [Palmieri M] [Ravaggi A] [Romani C] [Tassi R] [Roman JJ] [Burnett A] [Pecorelli S] [Cannon MJ]
Therapeutic vaccines for cervical cancer: dendritic cell-based immunotherapy. Nov 2005 - Curr. Pharm. Des.; 11(27):1381-6128 [PMID:16248803] [Santin AD] [Bellone S] [Roman JJ] [Burnett A] [Cannon MJ] [Pecorelli S]
Immunological treatment of ovarian cancer. May 2004 - Curr. Opin. Obstet. Gynecol.; 16(1):1040-872X [PMID:15128013] [Cannon MJ] [Santin AD] [O'Brien TJ]
Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer. Jul 2002 - Expert Rev Anticancer Ther; 2(1):1473-7140 [PMID:12113075] [Cannon MJ] [O'Brien TJ] [Underwood LJ] [Crew MD] [Bondurant KL] [Santin AD]
Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer. Jun 2002 - N. Engl. J. Med.; 346(22):1533-4406 [PMID:12037163] [Santin AD] [Bellone S] [Gokden M] [Cannon MJ] [Parham GP]
Novel immunotherapeutic strategies in gynecologic oncology. Dendritic cell-based immunotherapy for ovarian cancer. May 2002 - Minerva Ginecol; 54(2):0026-4784 [PMID:12032451] [Santin AD] [Bellone S] [Underwood LJ] [O'Brien TJ] [Ravaggi A] [Pecorelli S] [Cannon MJ]
Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer. Feb 2002 - Br. J. Cancer; 86(1):0007-0920 [PMID:11857027] [Santin AD] [Bellone S] [Ravaggi A] [Roman JJ] [Pecorelli S] [Parham GP] [Cannon MJ]
